Technology is key in sustainability, identity and security. At the forefront is synthetic biology, with some pointing to the tool as the answer to solving these pressing and emerging needs.
A doctor, researcher and former chronic migraine sufferer, has launched her own biotech startup company named KetoSwiss selling supplements that she argues can help control migraine pain by tapping into our own biological mechanisms.
Chemicals company Evonik, announces the development of a collagen form made using fermentation-based processes that do not use animal or human-derived materials.
The advent of synthetic biology, to essentially enhance microorganism capability is the radical approach being proposed to address micronutrient deficiencies and ‘engineer’ health.
The European Food Safety Authority (EFSA) has been told to revise its conflict of interest rules, after the European Ombudsman received complaints that GM working group members failed to provide full details of their indirect financial relationships with...
UK-based marine biotechnology firm Aquapharm Biodiscovery has received £4.2m in extra financing from its current investors which includes Tate & Lyle Ventures – a move it says will boost further development and commercialisation of its marine micro-organisms...
Italian biotechnology company, IRB, said a European patent is pending on the preparation and use of cell line cultures from the lilac-based extract that was awarded a patent in the US earlier this month.
Norwegian lipid research firm Natural says it has completed its
transformation to a biotechnology company after exiting all of its
supplement sales activities.
The leading vitamins supplier Roche Vitamins has opened a new
Biotech Center in Germany to develop biotechnological production
processes for new and existing products.
Gufic Biosciences, the Indian biotech company, is to expand into
the herbal medicine business with the planned launch of a range of
over-the-counter products.
